Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 5
2003 9
2004 14
2005 19
2006 13
2007 12
2008 16
2009 26
2010 25
2011 46
2012 40
2013 48
2014 69
2015 65
2016 66
2017 51
2018 80
2019 77
2020 98
2021 119
2022 126
2023 122
2024 133
2025 171
2026 50

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,342 results

Results by year

Filters applied: . Clear all
Page 1
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
Watts GF, Rosenson RS, Hegele RA, Goldberg IJ, Gallo A, Mertens A, Baass A, Zhou R, Muhsin M, Hellawell J, Leeper NJ, Gaudet D; PALISADE Study Group. Watts GF, et al. Among authors: zhou r. N Engl J Med. 2025 Jan 9;392(2):127-137. doi: 10.1056/NEJMoa2409368. Epub 2024 Sep 2. N Engl J Med. 2025. PMID: 39225259 Clinical Trial.
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia.
Rosenson RS, Gaudet D, Hegele RA, Ballantyne CM, Nicholls SJ, Lucas KJ, San Martin J, Zhou R, Muhsin M, Chang T, Hellawell J, Watts GF; ARCHES-2 Trial Team. Rosenson RS, et al. Among authors: zhou r. N Engl J Med. 2024 Sep 12;391(10):913-925. doi: 10.1056/NEJMoa2404147. Epub 2024 May 29. N Engl J Med. 2024. PMID: 38809174 Clinical Trial.
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia.
Ballantyne CM, Vasas S, Azizad M, Clifton P, Rosenson RS, Chang T, Melquist S, Zhou R, Mushin M, Leeper NJ, Hellawell J, Gaudet D. Ballantyne CM, et al. Among authors: zhou r. N Engl J Med. 2024 Sep 12;391(10):899-912. doi: 10.1056/NEJMoa2404143. Epub 2024 May 28. N Engl J Med. 2024. PMID: 38804517 Clinical Trial.
The Farm Animal Genotype-Tissue Expression (FarmGTEx) Project.
Fang L, Teng J, Lin Q, Bai Z, Liu S, Guan D, Li B, Gao Y, Hou Y, Gong M, Pan Z, Yu Y, Clark EL, Smith J, Rawlik K, Xiang R, Chamberlain AJ, Goddard ME, Littlejohn M, Larson G, MacHugh DE, O'Grady JF, Sørensen P, Sahana G, Lund MS, Jiang Z, Pan X, Gong W, Zhang H, He X, Zhang Y, Gao N, He J, Yi G, Liu Y, Tang Z, Zhao P, Zhou Y, Fu L, Wang X, Hao D, Liu L, Chen S, Young RS, Shen X, Xia C, Cheng H, Ma L, Cole JB, Baldwin RL 6th, Li CJ, Van Tassell CP, Rosen BD, Bhowmik N, Lunney J, Liu W, Guan L, Zhao X, Ibeagha-Awemu EM, Luo Y, Lin L, Canela-Xandri O, Derks MFL, Crooijmans RPMA, Gòdia M, Madsen O, Groenen MAM, Koltes JE, Tuggle CK, McCarthy FM, Rocha D, Giuffra E, Amills M, Clop A, Ballester M, Tosser-Klopp G, Li J, Fang C, Fang M, Wang Q, Hou Z, Wang Q, Zhao F, Jiang L, Zhao G, Zhou Z, Zhou R, Liu H, Deng J, Jin L, Li M, Mo D, Liu X, Chen Y, Yuan X, Li J, Zhao S, Zhang Y, Ding X, Sun D, Sun HZ, Li C, Wang Y, Jiang Y, Wu D, Wang W, Fan X, Zhang Q, Li K, Zhang H, Yang N, Hu X, Huang W, Song J, Wu Y, Yang J, Wu W, Kasper C, Liu X, Yu X, Cui L, Zhou X, Kim S, Li W, Im HK, Buckler ES, Ren B, Schatz MC, Li JJ, Palmer AA, Frantz L, Zhou H, Zhang Z, Liu GE; FarmGTEx Consortium. Fang L, et al. Among authors: zhou r. Nat Genet. 2025 Apr;57(4):786-796. doi: 10.1038/s41588-025-02121-5. Epub 2025 Mar 17. Nat Genet. 2025. PMID: 40097783 Review.
Effect of lateral versus supine positioning on hypoxaemia in sedated adults: multicentre randomised controlled trial.
Ye H, Chu LH, Xie GH, Hua YJ, Lou Y, Wang QH, Xu ZX, Tang MY, Wang BD, Hu HY, Ying J, Yu T, Wang HY, Wang Y, Ye ZJ, Bao XF, Wang MC, Chen LY, Wang XX, Zhang XB, Huang CS, Wang J, Lu YP, Luo FQ, Zhou W, Wang CG, Cheng H, Liu WJ, Luo J, Wu YQ, Li RR, Wang D, Hou LQ, Shi L, Zhang J, Wang K, Pi X, Zhou R, Yang QQ, Wan PL, Li H, Wu SJ, Song SW, Cui P, Shu L, Islam N, Fang XM. Ye H, et al. Among authors: zhou r. BMJ. 2025 Aug 19;390:e084539. doi: 10.1136/bmj-2025-084539. BMJ. 2025. PMID: 40829895 Free PMC article. Clinical Trial.
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).
Clark VC, Strange C, Strnad P, Sanchez AJ, Kwo P, Pereira VM, van Hoek B, Barjaktarevic I, Corsico AG, Pons M, Goldklang M, Gray M, Kuhn B, Vargas HE, Vierling JM, Vuppalanchi R, Brantly M, Kappe N, Chang T, Schluep T, Zhou R, Hamilton J, San Martin J, Loomba R. Clark VC, et al. Among authors: zhou r. Gastroenterology. 2024 Oct;167(5):1008-1018.e5. doi: 10.1053/j.gastro.2024.06.028. Epub 2024 Jul 2. Gastroenterology. 2024. PMID: 38964420 Free article. Clinical Trial.
1,342 results